Format

Send to

Choose Destination
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):229-237. doi: 10.1002/jcsm.12157. Epub 2016 Nov 16.

Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ Study.

Dodds RM1,2, Granic A2,3,4, Davies K2,3,4, Kirkwood TB3,4,5, Jagger C3,4,6, Sayer AA1,2,3,4,7,8.

Author information

1
Academic Geriatric Medicine, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, Hampshire, UK.
2
Ageing Geriatrics and Epidemiology, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, NE4 5PL, Tyne and Wear, UK.
3
NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, NE4 5PL, Tyne and Wear, UK.
4
Institute for Ageing, Newcastle University, Newcastle upon Tyne, NE4 5PL, Tyne and Wear, UK.
5
Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, Tyne and Wear, UK.
6
Institute of Health and Society, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
7
MRC Lifecourse Epidemiology Unit, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, Hampshire, UK.
8
NIHR Collaboration for Leadership in Applied Health Research and Care Wessex, University of Southampton, Southampton, Hamphsire, UK.

Abstract

INTRODUCTION:

Recognition that an older person has sarcopenia is important because this condition is linked to a range of adverse outcomes. Sarcopenia becomes increasingly common with age, and yet there are few data concerning its descriptive epidemiology in the very old (aged 85 years and above). Our aims were to describe risk factors for sarcopenia and estimate its prevalence and incidence in a British sample of the very old.

METHODS:

We used data from two waves (2006/07 and 2009/10) of the Newcastle 85+ Study, a cohort born in 1921 and registered with a Newcastle/North Tyneside general practice. We assessed sarcopenia status using the European Working Group on Sarcopenia in Older People (EWGSOP) definition. Grip strength was measured using a Takei digital dynamometer (Takei Scientific Instruments Ltd., Niigata, Japan), gait speed was calculated from the Timed Up and Go test, and lean mass was estimated using a Tanita-305 body fat analyzer. We used logistic regression to examine associations between risk factors for prevalent sarcopenia at baseline and incident sarcopenia at follow-up.

RESULTS:

European Working Group on Sarcopenia in Older People sarcopenia was present in 21% of participants at baseline [149/719 participants, mean age 85.5 (0.4) years]. Many participants had either slow gait speed or weak grip strength (74.3%), and hence measurement of muscle mass was frequently indicated by the EWGSOP definition. Incidence data were available for 302 participants, and the incident rate was 3.7 cases per 100 person years at risk. Low Standardized Mini-Mental State Examination, lower occupational social class, and shorter duration of education were associated with sarcopenia at baseline, while low muscle mass was associated with incident sarcopenia. Low body mass index (BMI) was a risk factor for both in a graded fashion, with each unit decrease associated with increased odds of prevalent [odds ratio (OR) 1.29, 95% confidence interval (CI): 1.21, 1.37] and incident (OR 1.20, 95% CI: 1.08, 1.33) sarcopenia.

CONCLUSIONS:

To our knowledge, this is the first study to describe prevalence and incidence of EWGSOP sarcopenia in the very old. Low BMI was a risk factor for both current and future sarcopenia; indeed, there was some evidence that low BMI may be a reasonable proxy for low lean mass. Overall, the high prevalence of sarcopenia among the very old suggests that this group should be a focus for future research.

KEYWORDS:

Incidence; Prevalence; Risk factors; Sarcopenia; Very old

PMID:
27897431
PMCID:
PMC5377385
DOI:
10.1002/jcsm.12157
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center